Divakara Gouda

Divakara Gouda

Auto-generated profile, based on publicly available information

Divakara Gouda


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LSLalitha Vani Sundararaman
Lalitha Vani Sundararaman
DGDivakara Gouda
Divakara Gouda
AKAnil Kumar
Anil Kumar
SSSumithra Sundararaman
Sumithra Sundararaman
Basavana GoudraBasavana Goudra
Basavana Goudra
The last two decades have proffered many remarkable choices in managing type 1 and type 2 diabetes mellitus. Leading the list are glucagon-like peptide-1 receptor agonists (GLP1RAs), the first of which, exenatide, was approved by the FDA in 2005. Two other major classes of drugs have also entered the market: dipeptidyl peptidase-4 (DPP-4) inhibitors, commonly known as gliptins and approved in 2006, and sodium–glucose cotransporter-2 (SGLT-2) inhibitors, with the first approval occurring in 2013. These drugs have revolutionized the treatment of diabetes. Additionally, on the horizon, the once-weekly basal insulin analog insulin icodec and the once-weekly combination of insulin icodec and semaglutide are expected to be available in the future. Beyond glycemic control, GLP1RAs have exhibited benefits in conditions associated with diabetes, including hypertension, dyslipidemia, non-alcoholic steatohepatitis, as well as in neurodegenerative diseases such as Alzheimer’s disease. Additionally, emerging research suggests potential roles in certain types of cancer, infertility, and associative learning. Major cardiovascular events seem to be lower in patients on GLP1RAs. While some evidence is robust, other findings remain tenuous. It is important that clinicians are familiar with current research in order to provide optimal evidence-based care to patients. In the not-too-distant future, there may be a case to prescribe these drugs for benefits outside diabetes.

16 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Basavana GoudraBasavana Goudra
Basavana Goudra
PCPrarthna Chandar
Prarthna Chandar
DGDivakara Gouda
Divakara Gouda
HYHarrison Yang
Harrison Yang
GMGanan Muhunthan
Ganan Muhunthan
MGMichael Stuart Green
Michael Stuart Green
Background: Navigational bronchoscopy (NB) enables precise sampling of peripheral and central pulmonary nodules using shape-sensing or electromagnetic guidance. A major challenge is anesthesia-induced atelectasis, which alters lung anatomy, reduces registration accuracy, and is known to lower diagnostic accuracy. To counteract this, ventilatory protocols such as the Ventilatory Strategy to Prevent Atelectasis (VESPA) and the Lung Navigation Ventilation Protocol (LNVP) have been recommended. Their adoption and clinical impact, however, remain uncertain. Methods: We conducted a retrospective review of 224 consecutive NB procedures performed under general anesthesia at a single academic medical center (January 2020–August 2024). Demographic, anesthetic, and ventilatory data were extracted from electronic records. Outcomes included navigational success (ability to reach the lesion) and diagnostic accuracy (concordance between bronchoscopic diagnosis and final clinical diagnosis after follow-up). Ventilatory practices were compared with published VESPA and LNVP recommendations. Results: Navigational success, defined as successful advancement of the bronchoscope to the target lesion with tissue acquisition, was achieved in 89.2% of cases. Overall diagnostic accuracy, defined as concordance between bronchoscopic diagnosis and final clinical diagnosis after follow-up, was 81.7%. Ventilatory management consistently diverged from recommended protocols. Most patients were ventilated with FiO2 > 0.6, PEEP in the range of 7–10 cm H2O, and tidal volumes of 300–500 mL. The only recommended maneuver systematically applied was recruitment immediately after intubation. Despite widespread deviation from both VESPA and LNVP, diagnostic performance remained favorable relative to published benchmarks. No major anesthesia-related complications occurred. Conclusions: In this retrospective series, navigational success comparable to published studies that adapted strict ventilation protocols was achieved with also comparable diagnostic accuracy without strict adherence to predefined ventilatory strategies. Recruitment maneuvers may represent the most influential component of current protocols, but institutional factors such as procedural expertise and case volume likely contributed to outcomes. Prospective studies are warranted to determine whether standardized ventilatory protocols are necessary for optimizing NB performance.